Bacteria coordinate cellular behaviors using a cell-cell communication system termed quorum 22 sensing. In Vibrio harveyi, the master quorum sensing transcriptional factor LuxR directly 23 regulates >100 genes in response to changes in population density. Here, we show that LuxR 24 derepresses quorum sensing loci by competing with H-NS, a global transcriptional repressor 25 that oligomerizes on DNA to form filaments and bridges. We first identified H-NS as a repressor 26 of bioluminescence gene expression, for which LuxR is a required activator. In an hns deletion 27 strain, LuxR is no longer necessary for transcription activation of the bioluminescence genes, 28
Introduction 41
In nature, bacteria live in complex communities of microbes where competition for 42 resources is constant. Thus, detection and identification of neighboring cells in the community is 43 important for survival in many niches. To achieve this feat, bacteria use cell-cell communication 44 called quorum sensing (QS) to detect and differentiate both the number and type of cells in the 45 local vicinity (1). QS employs small signaling molecules called autoinducers (AIs). Because AIs 46 are constitutively produced and released, their local extracellular concentration functions as a 47 proxy for the number of neighboring cells. The marine pathogen Vibrio harveyi produces three 48 harveyi hns L30P allele to test its activity. As expected, the Δhns strain expressing H-NS L30P 140 phenocopied the Δhns strain and produced more bioluminescence than wild-type during 141 exponential phase (Fig. 1D ). Even at high concentrations of IPTG, this mutant is unable to 142 complement the Δhns strain. From these data, we conclude that V. harveyi H-NS represses 143 bioluminescence in a concentration dependent manner and is a functional homologue of H-NS 144 from E. coli. Further, the role of H-NS in repression of luxCDABE occurs at HCD; at LCD, 145 deletion of hns has no impact on bioluminescence. 146 147
H-NS and LuxR co-regulate 124 genes 148
To determine whether other promoters are regulated by H-NS and LuxR in a similar 149 manner to P luxCDABE , we used RNA-seq to define the regulons for LuxR and H-NS. For the RNA-150 seq, we compared transcripts in a Dhns strain to a wild-type strain. Conventionally, we have 151 performed QS-related RNA-seq analyses at OD 600 = 1.0 because this is when HCD is reached. 152 Therefore, we also performed the wild-type vs. Dhns RNA-seq at this point in the growth curve. 153
We observed that H-NS regulates 726 genes (>2-fold, p < 0.05; Fig. 2A , dataset S1) in V. 154 harveyi, which is strikingly comparable to the 701 genes regulated by H-NS in V. cholerae (21) . 155
Among the 726 genes, 596 are repressed by H-NS. Because H-NS is a global repressor and 156 thus functions in the opposing manner to LuxR at luxCDABE, we hypothesized that LuxR acts to 157 derepress H-NS-bound loci. Indeed, the luxCDABE genes were absent from the H-NS regulon 158 in the wild-type background, which supports this hypothesis. To determine if the presence of 159
LuxR affects H-NS gene regulation at other loci, we next performed RNA-seq comparing a 160
DluxR strain to a DluxR Dhns strain. Under these conditions, H-NS regulates 824 genes (>2-fold, 161 p < 0.05; Fig. 2A , dataset S1) and, as expected, the luxCDABE genes were present. However, 162 only 430 genes are repressed by H-NS in this comparison. Together, these RNA-seq data show 163 that H-NS regulates a similar number of genes in the presence or absence of LuxR, though the 164 scale and direction of regulation varies widely. Among the combined genes in the H-NS 165 regulons (wild-type and DluxR backgrounds combined), 178 genes overlapped with the 166 previously identified 308-gene LuxR regulon (>2-fold, p < 0.05; Fig. 2A; (7) ). These genes 167 include many systems previously shown to be highly regulated by LuxR, including the 168 luxCDABE genes, the type III secretion operons, the proXWV glycine betaine transport system, 169
and several ABC transport systems, among others. From these data, we conclude that H-NS 170
and LuxR are relevant global co-regulators in V. harveyi. 171 172
LuxR and H-NS co-occupy and co-regulate 19 promoters 173
Based on our bioluminescence and transcriptomic data, our working hypothesis was that 174
as LuxR protein concentration increases during QS, LuxR binds to promoters containing LuxR 175 binding sites to displace H-NS, which alleviates promoters from H-NS-mediated repression. To 176 test this hypothesis and identify promoters that are bound by both LuxR and H-NS, we used 177
ChIP-seq to define global binding profiles for LuxR and H-NS individually. FLAG-luxR and hns-178 FLAG unmarked alleles were each introduced separately into V. harveyi BB120, and ChIP-seq 179 was performed comparing each of the FLAG-tagged mutant strains to the wild-type strain. We 180 identified 506 binding peaks for LuxR and 237 binding peaks for H-NS across the genome (Fig.  181 2B, dataset S2). We also analyzed LuxR and H-NS binding peaks to determine how many are 182 proximal to each other and found that LuxR and H-NS peaks overlap at 68 regions ( Fig. 2B , 183 dataset S2). Furthermore, we analyzed the distance between H-NS and LuxR peaks across the 184 genome. We observed distinct types of LuxR binding site locations using this analysis: 1) LuxR 185 binding sites that directly overlap with H-NS binding sites, 2) LuxR binding sites that are 186 proximal to H-NS binding sites (within ~1,000 bp), and 3) LuxR binding sites that are distant 187 from H-NS peaks (>5,000 bp away) ( Fig. 2C ). Interestingly, most LuxR peaks within 1,000 bp of an H-NS peak are proximal to genes that are co-regulated by both LuxR and H-NS (red dots, 189 Fig. 2C ). As expected, we observed LuxR and H-NS peaks at the luxCDABE promoter ( Fig. 3A) , 190 and no peaks at a control locus (clpP; Fig. 3B ). 191
The ChIP-seq experiments described above were performed with cells collected at HCD 192 (OD 600 = 1.0), similar to our RNA-seq analyses because this is the time point is when LuxR 193 protein is maximally produced prior to stationary phase (5) . Based on our hypothesis that LuxR 194 displaces H-NS at HCD, we reasoned that our experimental ChIP-seq setup may have missed 195 H-NS binding sites that were obscured by competition with LuxR because they were collected at 196 the HCD state. Therefore, to observe all H-NS-bound sites in the genome, we performed ChIP-197 seq with H-NS-FLAG in a DluxR mutant strain background. As we predicted, the number of H-198 NS binding peaks increased from 237 to 302 in the absence of LuxR (dataset S2). The number 199 of co-occupied H-NS and LuxR loci increased from 68 to 87 in the absence of LuxR (dataset 200 S2). By examining these 87 regions further in the context of transcriptomic data and gene 201 organization, we narrowed this list down to 65 regions that are co-occupied by LuxR and H-NS 202 (dataset S2). Among these are 28 promoters controlling expression of 63 genes that are also 203 co-regulated by LuxR and H-NS (dataset S2). Examples of binding peaks at co-regulated and/or 204 co-occupied regions are shown in Figure 3 . The remaining co-occupied loci are not present in 205
the LuxR/H-NS co-regulon. These genes may be regulated <2-fold, regulated by only one of 206 these proteins, or regulated only under specific conditions that we did not test. From these data, 207
we conclude that H-NS and LuxR co-localize throughout the genome to co-regulate genes. 208 209
LuxR binding alters H-NS binding profiles in vivo 210
From the ChIP-seq data, we also observed substantial differences in H-NS peak heights 211 in the presence or absence of LuxR. We hypothesized that these profile changes are due to 212 binding of LuxR and displacement of H-NS. To ensure peak height differences were not due to 213 differences in sample preparation (i.e. library preparation/number of sequencing reads), we 214 identified 98 loci that contain H-NS peaks but are devoid of any LuxR peaks. We reasoned that 215 these peaks would not be directly influenced by LuxR and thus we could normalize the H-NS 216 sequencing read distribution to these peaks (normalization procedure detailed in methods). 217
Following normalization, we re-compared these 98 peaks and found that the loci remained 218 significantly correlated between wild-type and ΔluxR backgrounds ( Fig. S5 ). With the read 219 counts normalized, we then analyzed the H-NS peak heights at LuxR-bound loci. Each of the 220 loci which are directly activated by LuxR/repressed H-NS showed an increase in H-NS peak 221 height in the absence of LuxR (Fig. 3A , 3C, 3D, 3E, 3F), indicating increased binding of H-NS at 222 these loci. Interestingly, when we analyzed the difference in H-NS peak heights between the 223 wild-type and ΔluxR backgrounds, we noticed a single LuxR binding site often influenced both 224 H-NS peaks, even if separated by 2 kb as is the case with VIBHAR_02472 ( Fig. 3E ). Even at 225 two loci that LuxR does not regulate under our tested conditions, there is a measurable H-NS 226 peak height difference when LuxR is bound compared to the DluxR background ( Fig. 3G, 3H) . 227
Another intriguing property of the H-NS ChIP-seq profile is the frequent occurrence of 228 doublets in which two peaks of similar height are proximal to one another. This phenomenon is 229 also detectable in H-NS ChIP-seq experiments performed in V. cholerae (22) . We suspect that 230 these peak profiles represent bridges formed by H-NS. While the peak height is generally 231 similar within doublets, the distance between peaks is highly variable ranging from ~400 bp to 2 232 kb. We analyzed the H-NS ChIP-seq data for binding sites that matched these parameters (2 233 similarly sized peaks within 2 kb of each other). We identified 52 H-NS doublets throughout the 234 genome, and 32 are proximal to a LuxR binding site (within 1 kb). The notable disruption of 235 these H-NS doublets by the presence of LuxR (e.g., Fig. 3A Based on our observations of LuxR activation and H-NS repression activities at the 242 luxCDABE promoter, our working hypothesis was that as LuxR protein concentration increases 243 during QS, LuxR binds to P luxCDABE and displaces H-NS, which alleviates promoters from H-NS-244 mediated repression. As a control, we examined gene expression of the luxCDABE genes to 245 compare to our bioluminescence assays and previously published expression data. The RNA-246 seq data for the luxC gene indicate that Dhns cells express ~2-fold more luxC transcripts than 247 wild-type cells at OD 600 = 1.0 ( Fig. 2D ). As expected, the DluxR strain exhibits very low levels of 248 luxC transcript ( Fig. 2D ), which has been shown previously (23) and is evidenced by lack of 249 bioluminescence production ( Fig. 1A) . We were therefore surprised to observe that the ΔluxR 250
Dhns strain restored luxC transcripts with only ~2-fold fewer transcripts compared to wild-type 251 and ~4-fold fewer than the Dhns strain ( Fig. 2D ). This result suggests that LuxR is only required 252 for luxC transcription in the presence of H-NS. However, the bioluminescence production of the 253 ΔluxR Δhns strain remains very low ( Fig. 2D ), suggesting that a posttranscriptional mechanism 254 of regulation coordinated via LuxR is required for bioluminescence production. 255
To test whether this occurs at other LuxR/H-NS co-regulated and co-occupied 256 promoters, we examined the other 9 loci in addition to luxCDABE that are activated by LuxR 257 and repressed by H-NS (dataset S2). Each of the 37 genes under control of the 13 promoters 258
show the same pattern of gene expression as luxC: transcript levels are lowest in the DluxR 259 strain for all genes, suggesting that LuxR is required for activation of these genes (Fig. 2D) . 260
However, when hns is deleted in the ΔluxR background, transcript levels are completely or 261 partially restored to wild-type levels ( Fig. 2D ). From these data, we conclude that LuxR is not 262 required for transcription activation of these promoters in the absence of H-NS. 263
264

H-NS is evicted from promoter regions as cells transition from LCD to HCD 265
To investigate the role of LuxR in H-NS localization at promoters, we developed a ChIP-266 qPCR assay that mimics various QS states to quantify relative amounts of LuxR and H-NS 267 protein occupancy at promoters. These experiments were performed using a strain background 268 in which the genes encoding the HAI-1 autoinducer synthase and CAI-1 and AI-2 receptors 269 were deleted (TL25: ΔluxPQ, ΔluxM, ΔcqsS) (5) . This strain responds solely to exogenously 270 supplied HAI-1. Based on previously established concentrations of HAI-1 that mimic the 271 transition states between LCD and HCD, we tested a range of synthetic HAI-1 from 0-1000 nM. 272
When either no HAI-1 or low concentrations of HAI-1 are added to this strain, both aphA/luxR 273 transcripts and AphA/LuxR proteins are detected (5) . As the HAI-1 concentration added 274 increases to 1000 nM, aphA transcript sharply decreases and AphA protein is no longer 275 detected, whereas luxR transcript and LuxR protein increase (5) . To pinpoint AI concentrations 276 that mimic LCD, mid cell density (MCD), and HCD, a bioluminescence induction assay was 277 used. Based on the bioluminescent output, we found that 0/4 nM, 40 nM, and 1000 nM were 278 sufficient to replicate light production levels present at LCD, MCD, and HCD (Fig. S2 ). The 279
FLAG-LuxR and H-NS-FLAG alleles were individually introduced into the TL25 background, and 280
ChIP was performed using these strains grown with the above HAI-1 concentrations. The 281 immunoprecipitated DNA was analyzed via qPCR directed at 7 promoters that showed strong, 282 overlapping peak signals for LuxR and H-NS. The promoter region upstream of clpP was used a 283 negative control for this experiment because no ChIP-seq peaks were detected for LuxR/H-NS 284 protein occupancy increases at the promoter while H-NS occupancy decreases as cells 287 transition from LCD to HCD (Fig. 4A ). This trend was conserved at 6 additional promoters in 288 which we observed a marked increase in LuxR occupancy with a simultaneous decrease in H-289 NS occupancy ( Fig. 4C-H) . While the overall trend of decreasing H-NS occupancy is consistent 290 across promoters, the amount of HAI-1 required to reach maximum H-NS displacement is 291 variable. Some promoters, such as P luxC and P 02100 , require 1000 nM HAI-1, whereas others, 292 such as P 01749 and P 02472 , require ≤40 nM HAI-1. Taken together, these data support the 293 hypothesis that LuxR accumulation coincides with the displacement of H-NS from QS 294
promoters. 295
To test if LuxR is necessary and/or sufficient to displace H-NS from QS loci in vivo, we 296 constructed the TL25 FLAG-hns ΔluxR strain. We performed our ChIP-qPCR analysis to 297 monitor changes in H-NS occupancy in the absence of LuxR. We observed that the relative 298 amount of H-NS present at a promoter is higher in the ΔluxR background compared to wild-type 299 at some or all concentrations of HAI-1 ( Fig. 4B-H) . While overall H-NS occupancy is higher in 300 these profiles, we do observe H-NS displacement in the absence of LuxR at certain promoters. 301
For instance, at P 02472 H-NS displacement is observed between 0-40 nM HAI-1 and at P 01749 H-302 NS is displaced between 4-40 nM HAI-1. These results are not surprising as LuxR likely works 303 alongside other transcription factors to activate transcription; thus, the observation of H-NS 304 displacement in the absence of LuxR can be attributed to the action of other regulators. The 305 results of these experiments provide evidence that LuxR is required for maximal H-NS 306 displacement at QS promoters. 307 308
LuxR displaces H-NS from promoter DNA in vitro 309
The results of the ChIP-qPCR experiments showed that increasing concentrations of AI 310
and LuxR-binding results in lower H-NS binding at QS promoters in vivo. To determine whether 311
LuxR is able to displace H-NS from DNA in vitro, we first used a bioinformatics approach (FIMO 312 software, (24)) to identify putative H-NS binding sites in the luxCDABE promoter. Using the 313 high-affinity H-NS nucleation site identified in E. coli (TCGATAAATT) (25), we identified 13 314 potential sites in P luxCDABE , many of which overlap with the seven established LuxR binding sites 315 Table S1 ). Next, we used electrophoretic mobility gel shift assays (EMSAs) and 316 performed titration curves with purified 6xHis-H-NS (referred to as H-NS) and LuxR individually 317 to determine the binding kinetics for each protein with luxCDABE promoter DNA. For both sets 318 of reactions, we observed the DNA shift to a larger molecular weight, suggesting that all the 319 DNA was bound ( Fig. 5B ). For H-NS, a steep binding curve was observed, which likely reflects 320 the cooperative DNA binding activities of H-NS (26, 27) . For LuxR, multiple intermediate LuxR-321 DNA bands were observed, as expected (7). 322
To examine competition between LuxR and H-NS, we generated reactions with both H-323 NS and LuxR added to luxCDABE promoter DNA. We added a constant amount of H-NS and 324 varying concentrations of LuxR. We observed that increasing concentrations of LuxR 325 incrementally shifted the migration of the nucleoprotein complex to mirror that of the LuxR-326 P luxCDABE complex (Fig. 5C ). This result suggests that LuxR evicts H-NS from this promoter. To 327 determine whether any H-NS protein remained bound to the shifted DNA substrate, EMSA 328 reactions were then transferred to a nitrocellulose membrane such that the proteins associated 329 with bound DNA could be monitored via western blot. We observed that as LuxR concentration 330 increases across reactions, the H-NS protein signal corresponding to the H-NS-P luxCDABE bound 331 complex decreases. In parallel, the signal corresponding to unbound H-NS accumulates (Fig.  332 5C). 333
The experiment described above was performed in the absence of competitor DNA 334 because H-NS can bind to DNA non-specifically. To verify that the displacement of H-NS was 335 dependent on LuxR associating with specific binding sites rather than non-specific interactions 336 with the DNA, we performed the same competition experiment in the presence of competitor 337 DNA (poly[dI-dC]) to limit the amount non-specific protein-DNA interactions. Under these 338 conditions, LuxR remains able to displace H-NS from P luxCDABE DNA (Fig. S3C) . Importantly, we 339 tested a LuxR R17C DNA binding mutant (8) and found that it was unable to displace H-NS from 340 the luxCDABE promoter ( Fig. 5D ). This result confirms that LuxR eviction of H-NS relies on 341
LuxR DNA binding activity. Next, we extended these experiments to two additional promoters 342 that are repressed by H-NS and activated by LuxR (P 02100 and P 03626 ). Competition between H-343 NS and LuxR was observed using these promoters as well ( Fig. S3A, S3B ), indicating that LuxR 344 eviction of H-NS is a conserved mechanism at multiple loci. 345
Lastly, we wanted to examine the influence of H-NS on the binding of RNAP to P luxCDABE 346 promoter DNA. Using the same competitive EMSA experimental design as described above, we 347 pre-bound the P luxCDABE substrate with H-NS and titrated in various amounts of purified E. coli 348 10xHis-RNAP (referred to as RNAP). With increasing concentrations of RNAP, the H-NS-DNA 349 complex showed slower migration through the gel (Fig. S4 binding sites are AT-rich sequences, it is unsurprising that they may compete for similar sites at 378 a promoter. 379
Within the 506 and 302 peaks identified for LuxR and H-NS, respectively, 87 peaks 380 overlapped and were proximal to an ORF (≤500 bp). The LuxR ChIP-seq profile previously 381 published identified 1165 LuxR binding peaks (8) . However, that previous experiment was 382 performed with FLAG-luxR expressed from a multi-copy plasmid in at DluxR background, which 383 is the likely reason for the increased number of LuxR binding peaks identified. Overall, the 384
ChIP-seq data show that QS loci are regulated via the competitive binding dynamics of LuxR 385 and H-NS (and likely other regulators). The function of LuxR at 13 of these promoters appears 386 to be eviction of H-NS, and this results in activation of gene expression. The nucleoprotein 387 bridges formed by H-NS may inhibit transcription initiation, trap elongating RNAP, and/or affect 388 the topology of the DNA such that RNAP elongation is inhibited. Importantly, we observed that 389 at many promoters, the two H-NS peaks were positioned such that the promoter was between 390 the peaks. If these peaks indeed represent DNA-H-NS-DNA bridges, it is likely that even if 391 RNAP can initiate transcription effectively, the bridge would block elongation. In addition, our 392
finding that several H-NS peaks colocalize near genes repressed by LuxR presents the 393 question: does LuxR also function alongside H-NS to repress gene expression? Additional 394 experimentation will be necessary to properly address this question, but we speculate that LuxR 395 may be sufficient to displace transcriptional activators that prevent H-NS from binding to these 396 loci. In support of this theory is the finding that HapR and H-NS function together to 'double-lock' 397 the vieSAB promoter in V. cholerae (29) . 398
Perhaps the most surprising evidence that LuxR functions to oppose the action of H-NS 399 globally is the observation that transcript levels of many QS genes are restored to wild-type 400 levels in the ΔluxR Δhns strain. This finding implies that, at HCD, LuxR becomes dispensable 401 when H-NS is not present for a subset of genes. It is important to note that, for at least 402 luxCDABE, while transcript levels are restored to near wild-type levels in the ΔluxR Δhns strain, 403 the bioluminescence phenotypic output remains very low. This result suggests that the 404 bioluminescence genes are controlled both transcriptionally and post-transcriptionally. One 405 possibility is that LuxR regulates the expression of a sRNA or an RNA-binding protein that is 406 necessary for translation of these genes. Alternatively, a cis-acting RNA regulatory element 407 such as a riboswitch or RNA thermometer may be regulating the translation of the luxCDABE 408 mRNA. Further analyses will be required to test these possibilities. 409
From the collective work on the luxCDABE promoter, it is clear that these genes are 410 highly regulated by multiple mechanisms, likely due to the cost of expressing these proteins at 411 such high levels. At LCD, the ChIP-seq H-NS peak profile suggests that H-NS is bound to the 412 luxCDABE promoter in a nucleoprotein bridge. LuxR protein levels are insufficient to stimulate 413 transcription of the luxCDABE genes, even in the absence of hns. Thus, there are likely other 414 regulatory mechanisms acting at the transcriptional and/or posttranscriptonal levels to repress 415 expression at LCD. As population density increases and LuxR protein levels rise, LuxR binds to 416 the binding sites in the luxCDABE promoter, and the H-NS nucleoprotein filament is destabilized 417 resulting in the mass eviction of H-NS monomers/dimers from the DNA. Once the promoter has 418 been purged of H-NS, it is probable that LuxR and other transcription factors, such as IHF, 419 remodel promoter architecture to poise RNAP for transcription of the luxCDABE genes. LuxR 420 interaction with RNAP has been established at the luxCDABE promoter (9), and likely is 421 responsible for the ~4-fold increase in transcription in the presence of LuxR. The observation 422 that RNAP can bind to H-NS-bound DNA but is unable to displace H-NS is suggestive that 423 RNAP recruitment is not the rate-limiting step for expression of the luxCDABE operon. Instead, 424 it is likely that RNAP can bind to the luxCDABE promoter but remains incompetent for 425 transcription. This hypothesis aligns well with the observation that RNAP can partially elongate 426 through H-NS-DNA bridges but inevitably pauses due to the topological constraints of the H-NS-427 DNA bridge (13). Additionally, H-NS filaments can interact with promoter-bound RNAP to inhibit 428 open complex formation (30). While the experiments performed in this study are insufficient to 429 identify which mechanism(s) occurs at LuxR-dependent promoters, we speculate that the 430 mechanism is probably promoter dependent.
We therefore propose an updated model for the activation of QS genes (such as the 432 luxCDABE operon) in V. harveyi (Fig. 6) . At LCD, the amount of LuxR in the cell is inadequate 433 to compete against H-NS for binding of QS promoter DNA. Under these conditions, H-NS 434 remains bound to QS promoters as a nucleoprotein bridge, thereby silencing gene expression. 435
As the population transitions to HCD, the intracellular concentration of LuxR increases ~10-fold 436 (31). Given the gradual accumulation of LuxR as well as the variation of binding site affinities, 437
LuxR likely associates with high-affinity binding sites followed by moderate to low affinity sites 438 within promoter regions. We propose that this incremental binding of LuxR to the promoter is 439 part of a stepwise mechanism that allows for the systematic displacement of H-NS 440 nucleoprotein bridges and filaments. Once H-NS bridges have been remodeled and H-NS 441 displaced from the promoter, LuxR aids in the recruitment and/or stabilization of RNA 442 polymerase to increase transcription levels (9) . Thus, in a Dhns strain, LuxR is not required for 443 transcription, but the presence of LuxR increases transcription by interaction with RNA 444
polymerase. 445
Collectively, biochemical and genetic studies of LuxR/HapR proteins have made 446 significant progress in determining the mechanism of transcriptional activation and repression 447 by these master QS regulators. LuxR-type proteins function alongside IHF, directly oppose H-448 NS, associate with RNAP, and stimulate and/or block activities of other transcription factors 449 (4, 7, 9, 10, (32) (33) (34) . Importantly, though many of these mechanisms are conserved in Vibrio 450 species and at multiple promoters, we surmise that the transcriptional control of each QS 451 promoter is likely different. The luxCDABE promoter provides an easily monitored system for 452 examining possible LuxR functions that can be tested at other promoters. Our observation that 453
LuxR counter-silencing of H-NS is globally functional in V. harveyi and that similar observations 454 have been reported in other QS bacteria alludes that H-NS counter-silencing via QS regulators 455 could represent a conserved QS regulatory mechanism. 456 457
Methods 458
Bacterial strains and media 459
The E. coli S17-1λpir strain was used for cloning purposes, and the E. coli BL21 (DE3) strain 460 was used for overexpression and purification of all proteins (Supplemental information Table  461 S2). E. coli strains were cultured at 37 °C with shaking (250-275 RPM) in Lysogeny Broth (LB) 462 medium with 40 µg/mL kanamycin, 100 µg/mL ampicillin, and/or 10 µg/mL chloramphenicol 463 when selection was required. V. harveyi BB120 was recently reclassified as Vibrio campbellii 464 BB120 (a.k.a., ATCC BAA-1116) (35), but for consistency in the literature, we refer to it as V. 465
harveyi. BB120 and derivatives were cultured at 30 °C with shaking (250-275 RPM) in Luria 466
Marine (LM) medium with 250 µg/mL kanamycin, 5/10 µg/mL chloramphenicol, and/or 50 µg/mL 467 polymyxin B when selection was required. Plasmids were transformed into electrocompetent E. 468 coli S17-1λpir cells and subsequently conjugated into V. harveyi strains. V. harveyi 469 exconjugants were selected using polymyxin B (50 U/mL). 470 471
Bioluminescence assays 472
Bacterial cultures were back-diluted to OD 600 = 0.0005 in 50 mL LM in flasks and grown shaking 473 at 275 RPM. For the standard assay (Fig. 1A) , optical density (OD 600 ) was measured using a 474 
Molecular and chemical methods 482
PCR was performed using Phusion HF polymerase (New England Biolabs). All restriction 483 enzymes and T4 polynucleotide kinase were purchased from New England Biolabs and used 484 according to the manufacturer's protocol. Site-directed mutagenesis was performed using 485
Phusion HF polymerase (New England Biolabs) following the QuikChange mutagenesis 486 protocol (Stragene). All oligonucleotides were ordered from Integrated DNA Technologies (IDT). 487
Oligonucleotides used for EMSAs and qPCR are listed in Supplemental Information Table S4 . 488 PCR products and plasmids were sequenced using Eurofins Genomics. All plasmids used in 489 this study are listed in Supporting Information Table S3 , and cloning procedures are available 490 upon request. DNA samples were resolved using 1% agarose (1x TBE). V. harveyi autoinducer 491 1 (HAI-1) was synthesized using a previously published protocol (36). 492 493
Construction of deletion/epitope-tagged strains 494
All V. harveyi BB120 and KM669 derivative strains in this study were constructed following a 495 previously published technique (7) . Briefly, the pRE112 suicide vector was used to construct 496 unmarked deletions or insertions of epitopes in which 1000 bp of upstream and downstream 497 flanking sequence was cloned into pRE112. The pRE112 derivatives were conjugated into V. 498 harveyi and selected on chloramphenicol to induce chromosomal recombination of the plasmid. 499
Subsequently, the plasmid was excised via counterselection on 20-25% sucrose. Cells in which 500 the plasmid excision yielded a non-WT locus were detected via colony PCR. All gene deletions 501 were confirmed by DNA sequencing. 502
RNA-seq 504
To isolate RNA, cells were back-diluted to OD 600 = 0.005 and grown shaking at 30°C until OD 600 505 = 1.0. RNA was collected, extracted, DNase-treated, and purified as described previously (7) . 506
RNA-seq was performed as described previously (7) . Sequence data were deposited in the 507 National Center for Biotechnology Information Gene Expression Omnibus database (NCBI 508 GEO). 509 510
Chromatin immunoprecipitation 511
Cells were grown to an OD 600 of 1.0 and protein/nucleic acids were crosslinked using 1% 512 formaldehyde at 30 °C for 30 minutes. Crosslinking was quenched with the addition of 0.42 M 513 glycine and incubated at 30 °C for 5 minutes. 10 ODs of cells were harvested for each replicate 514 and cell pellets were stored at -80 °C. Cells were lysed using lysis buffer (1x Bugbuster 515 (Milipore), 1% Triton X-100, 1 mM PMSF, 50 µg/mL lysozyme, and 1x protease inhibitors) at 516 room temperature for 30 minutes on a nutator. Protease inhibitor cocktail (100x stock) contained 517 the following: 0.07 mg/mL phosphoramidon (Santa Cruz), 0.006 mg/mL bestatin 518 (MPbiomedicals/Fisher Scientific), 1.67 mg/mL AEBSF (DOT Scientific), 0.07 mg/mL pepstatin 519 A (Gold Bio), 0.07 mg/mL E64 (Gold Bio). For ChIP-qPCR experiments, cell lysates were 520 sonicated using a Branson SFX 150 sonicator (30% amplitude, 10" pulse, 30" rest on ice, 4 521 cycles). For ChIP-seq experiments, cell lysates were sonicated using a Covaris S220 sonicator 522 (175 W peak incident power, 10% duty factor, 200 cycles per burst, 15-minute treatment time, 523 7.5 °C). After sonication, lysates were clarified via centrifugation at 15,000 RPM for 15 minutes 524 at 4 °C. FLAG-tagged proteins (LuxR was tagged N-terminally and H-NS was tagged C-525 terminally) were captured from clarified lysates using anti-FLAG agarose M2 beads (Sigma). 526
Lysates were incubated with the anti-FLAG resin for 90 minutes at room temperature in 527 immunoprecipitation buffer (50 mM HEPES-NaOH pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% 528 Triton X-100, 1 mM PMSF) on a nutator. After incubation with lysate, the beads were washed 529 with immunoprecipitation buffer, wash buffer 1 (50 mM HEPES-NaOH pH 7.5, 500 mM NaCl, 1 530 mM EDTA, 1% Triton X-100, 1 mM PMSF, 0.1% SDS), wash buffer 2 (10 mM Tris-HCl pH 8.0, 531 250 mM LiCl, 1 mM EDTA, 0.5% NP-40, 0.5% deoxycholate), and 10 mM TE. Nucleoprotein 532 complexes were eluted from the beads using elution buffer (50 mM Tris-HCl pH 7.5, 10 mM 533 EDTA, 1% SDS) at 65 °C for 30 minutes. Subsequently, nucleic acids were freed from 534 crosslinked protein via proteinase K digestion (1.8 mg/mL proteinase K, 2 hours at 42 °C, 16 535 hours at 65 °C). ChIPed DNA was purified using a PCR clean up kit (Qiagen). For input samples 536 (an aliquot of the sonicated, clarified lysate prior to incubation with beads), 1:1 ratio of lysate:10 537 mM Tris-HCl pH 8.0 and 1.8 mg/mL RNase A was added and incubated at room temperature for 538 10 minutes. Proteinase K treatment of input DNA was performed as described above. All ChIP-539 seq experiments were performed using three biological replicates. Immunoprecipitated DNA 540 concentration/quality was determined using an Agilent 2200 TapeStation and the DNA was 541 subsequently stored at -20 °C. 542 543
ChIP-seq and analyses 544
Chromatin immunoprecipitation for ChIP-seq experiments was performed as described above. 545
Sonication was performed using a Covaris S220 water bath sonicator; manufacturers' protocol 546 was followed to achieve ~150 bp DNA fragments. Immunoprecipitated chromatic DNA was 547 subjected to library preparation using NEBNext Ultra II DNA Library kit (NEB cat# E7645S). 548
Briefly, DNA fragments were end repaired and 5' phosphorylated, and a 3' end Adenosine-tail 549 was added. The products were ligated to a NEB hairpin adapter which contains an uracil at the 550 loop region. The adapter loop was opened by Uracil-Specific Excision Reagent (NEB) to excise 551 the uracil. The products were cleaned with Agencourt AMPure XP beads (Beckman Coulter cat# 552 A63882) but no size selection was applied. 10 (GSF1697) or 12 (GSF2248) PCR cycles were run using 8-nt barcoded oligos from NEBNext Multiplex Oligos barcode kit (NEB cat# 6609S). 554
The libraries were purified with Agencourt AMPure XP beads, multiplexed and sequenced on 555
NextSeq 500 (Illumina) with NextSeq75 High Output v2.5 kit (Illumina cat# 20024906) to 556 generate paired-end 2x42 bp reads. The read sequences were de-multiplexed using bcl2fastq 557 (software versions 2.1.0.31). ChIP-seq datasets were trimmed for quality and adapters using 558 ATCC BAA-1116 genome using bwa (v0.7.17). Peaks were identified using macs2 (v2.1.2) call 562 peak algorithm. To compare H-NS peak heights in the wildtype and DluxR mutant backgrounds 563 we had to normalize the data. Naively, we would just normalize each sample based on the 564 number of ChIP-seq reads mapped to the genome but it was unclear whether this would be 565 accurate given the potential interaction between H-NS and luxR. To validate this approach, we 566 identified 98 H-NS peaks that were not associated with luxR binding sites. The coverage 567 underlying the peak in each replicate was normalized to the number of reads mapped to the 568 genome. The mean, calculated across replicates, normalized peak coverage for these 98 luxR 569 independent peaks in the wildtype and DluxR strains was plotted. Linear regression shows that 570 there is a significant correlation between these points and that these points generates a line with 571 a slope close to 1 that passes close to the origin. Based on this result we proceeded to 572 normalize H-NS peak heights after normalizing by mapped reads. Distances between LuxR/H-573 NS and H-NS/H-NS peaks were performed using a custom script. Points were plotted as a 574 function of distance from LuxR peak to the nearest H-NS peak (x-axis) against distance from 575 nearest H-NS peak to the next closest H-NS peak (i.e. doublet, y-axis). H-NS doublet peaks 576 were identified using a custom script that searched for H-NS peaks within 2 kb of each other 577 that had a trough ≤80% of the lower of the two peaks. Sequence data were deposited in the 578 NCBI GEO database. 579 580
Quantitative PCR 581
ChIP input and elution samples were diluted 1:100 and 1:4, respectively, using nuclease free 582 H 2 O. qPCR reactions were performed using SensiFAST SYBR Hi-ROX (Bioline) according to 583 the manufacturer's guidelines. qPCR primers were designed to fit the following parameters: 584 amplicon size: 100-105 bp, primer size: 18-22 nt, and primer melting temperature: 56-60 °C. 585
Each reaction contained 2 µL of diluted DNA template (input or elution) and 0.4 µM of each 586 primer (total volume was 10 µL). qPCR reactions were incubated and monitored using a 587
LightCycler 4800 II (Roche). For quantification of relative enrichment, the following equation was 588 utilized: 2 CTinput -CTelution . All ChIP-qPCR experiments were performed with three biological 589 replicates. 590 591
Purification of LuxR, H-NS, and RNAP proteins 592
Recombinant, untagged LuxR and E. coli 6xHis-RNAP proteins were purified using protocols 593 previously reported (7, 9) . H-NS was purified by cloning the hns ORF into the pET28B 594 expression vector (Novagen) to generate a 6xHis tag on the C-terminus. The pET28B-hns-595 6xHis plasmid (pRC049) was transformed into NiCo21 E. coli (New England Biolabs), which 596 contains lacks several genes encoding proteins that readily contaminate immobilized metal 597 affinity chromatography purifications. The resulting strain, RRC226 (NiCo21-pRC049), was 598 grown at 30 °C to an OD 600 =0.6-0.8 and hns overexpression was induced using 1 mM IPTG for 599 Each point represents a LuxR binding site with the diameter corresponding to the strength of the 764 peak at that site; all 506 LuxR peaks are plotted. The distance between a LuxR peak and the nearest H-NS peak is plotted on the x-axis. The distance between the nearest H-NS peak and 766 the next proximal H-NS peak is plotted on the y-axis. Red points represent LuxR peaks that are 767 proximal to genes that are co-regulated by LuxR and H-NS while black points represent genes DNA and either H-NS (100, 150, 200, 250, 300 nM) or LuxR 790 (31.25, 62.5, 125, 250, 500, 1000, 2000 -792 NS and either 31.25, 62.5, 125, 250, 500, 1000, or (9) for construction of similar vectors] 
Figure Legends
